Patents by Inventor Chiara BERLATO

Chiara BERLATO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CCL22 and CCL17 cancer biomarkers
    Patent number: 10241118
    Abstract: The present invention provides methods of obtaining information relevant to monitoring and diagnosing cancer, particularly monitoring the progression or development of cancer, monitoring the response of cancer to treatment, diagnosing cancer, making a cancer prognosis, predicting the likelihood of a cancer responding to treatment and stratifying subjects having cancer. The methods involve determining the ratio of circulating CCL17 to circulating CCL22 in a sample from a subject.
    Type: Grant
    Filed: April 9, 2014
    Date of Patent: March 26, 2019
    Assignee: CANCER RESEARCH TECHNOLOGY LIMITED
    Inventors: Frances Balkwill, Chiara Berlato, Laura Fletcher
  • CCL22 AND CCL17 CANCER BIOMARKERS
    Publication number: 20160041187
    Abstract: The present invention provides methods of obtaining information relevant to monitoring and diagnosing cancer, particularly monitoring the progression or development of cancer, monitoring the response of cancer to treatment, diagnosing cancer, making a cancer prognosis, predicting the likelihood of a cancer responding to treatment and stratifying subjects having cancer. The methods involve determining the ratio of circulating CCL17 to circulating CCL22 in a sample from a subject.
    Type: Application
    Filed: April 9, 2014
    Publication date: February 11, 2016
    Applicant: CANCER RESEARCH TECHNOLOGY LIMITED
    Inventors: Frances BALKWILL, Chiara BERLATO, Laura FLETCHER